ES451655A1 - Un procedimiento para la preparacion de derivados de pirimi-dina. - Google Patents
Un procedimiento para la preparacion de derivados de pirimi-dina.Info
- Publication number
- ES451655A1 ES451655A1 ES451655A ES451655A ES451655A1 ES 451655 A1 ES451655 A1 ES 451655A1 ES 451655 A ES451655 A ES 451655A ES 451655 A ES451655 A ES 451655A ES 451655 A1 ES451655 A1 ES 451655A1
- Authority
- ES
- Spain
- Prior art keywords
- symbols
- translation
- preparation
- machine
- legally binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
- C09K19/06—Non-steroidal liquid crystal compounds
- C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
- C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
- C09K19/3444—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Liquid Crystal Substances (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un procedimiento para la preparación de derivados de pirimidina, de la fórmula general: **(Fórmula)** en la que cada uno de los símbolos X representa un átomo de nitrógeno y cada uno de los símbolos Y y Z representa -CH- o cada uno de los símbolos Y representa un átomo de nitrógeno y cada uno de los símbolos X y Z representa -CH- o cada uno de los símbolos Z representa un átomo de nitrógeno y cada uno de los símbolos X e Y representa -CH- y uno de los símbolos R1 y R2 representa un grupo de ciano y el otro representa un grupo alquílico de cadena lineal conteniendo de 1 a 7 átomos de carbono, un grupo alcoxílico de cadena lineal conteniendo de 1 a 7 átomos de carbono o un grupo alcanoiloxílico de cadena lineal conteniendo de 2 a 7 átomos de carbono.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1223575A CH622548A5 (en) | 1975-09-19 | 1975-09-19 | Liquid-crystal mixtures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES451655A1 true ES451655A1 (es) | 1978-01-01 |
Family
ID=4381138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES451655A Expired ES451655A1 (es) | 1975-09-19 | 1976-09-18 | Un procedimiento para la preparacion de derivados de pirimi-dina. |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE846316A (es) |
| CH (1) | CH622548A5 (es) |
| ES (1) | ES451655A1 (es) |
| SU (1) | SU655323A3 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3928267A1 (de) * | 1989-08-26 | 1991-02-28 | Merck Patent Gmbh | 5-oxy-2-phenylpyrimidine und fluessigkristallines medium |
| US5648021A (en) * | 1994-01-17 | 1997-07-15 | Hoechst Aktiengesellschaft | Phenanthrene derivatives and their use in liquid-crystalline mixtures |
-
1975
- 1975-09-19 CH CH1223575A patent/CH622548A5/de not_active IP Right Cessation
-
1976
- 1976-09-17 BE BE170712A patent/BE846316A/xx unknown
- 1976-09-17 SU SU762401700A patent/SU655323A3/ru active
- 1976-09-18 ES ES451655A patent/ES451655A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BE846316A (fr) | 1977-03-17 |
| SU655323A3 (ru) | 1979-03-30 |
| CH622548A5 (en) | 1981-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES394369A1 (es) | Procedimiento para la preparacion de derivados de la isoin-dolina. | |
| ES458688A1 (es) | Procedimiento de preparacion de nuevos derivados del ditiol-1,2. | |
| ES439548A1 (es) | Procedimiento para preparar derivados de ergolina. | |
| ES421430A1 (es) | Procedimiento para producir derivados carbostirilo. | |
| ES451655A1 (es) | Un procedimiento para la preparacion de derivados de pirimi-dina. | |
| ES437011A1 (es) | Un procedimiento para la preparacion de derivados de bencil-pirimidina. | |
| ES454823A1 (es) | Procedimiento para la preparacion de derivados de imidazo (1,2-a) piridina. | |
| ES451466A1 (es) | Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina. | |
| ES440438A1 (es) | Procedimiento para la preparacion de nuevos derivados de fe-nilbutazona. | |
| ES471125A1 (es) | Procedimiento para preparar derivados de 1-aminoindolina | |
| ES451741A2 (es) | Procedimiento para preparar derivados de naftiridina. | |
| ES386567A1 (es) | Procedimiento para la obtencion de derivados de piridazona. | |
| ES439180A1 (es) | Procedimiento para la preparacion de derivados de piperido- na. | |
| ES413044A1 (es) | Procedimiento de preparacion de fenotiazinas. | |
| GB1512620A (en) | Derivatives of dithiepino(1,4)(2,3-c)pyrrole | |
| ES445922A1 (es) | Procedimiento para preparar derivados de benzofuranona. | |
| ES420004A1 (es) | Un procedimiento para la preparacion de un derivado de ni- trosourea. | |
| IE780577L (en) | Propanolamines | |
| ES449570A1 (es) | Un procedimiento para la produccion de tetrazolo (a) quina- zol-5-onas. | |
| ES438557A1 (es) | Un procedimiento de preparacion de nuevos derivados de tia- zol. | |
| ES469883A1 (es) | Procedimiento para la obtencion de derivados de la hidroxi-4tiazolidinationa-2 | |
| ES402381A1 (es) | Un procedimiento para la preparacion de benzopiranos susti-tuidos. | |
| ES460297A1 (es) | Un compuesto. | |
| ES399221A1 (es) | Un procedimiento para la preparacion de un cromenol. | |
| ES457089A1 (es) | Procedimiento para la preparacion de nuevos colorantes basi-cos de antraquinona. |